News
TikTok parent ByteDance raises cash for drug AI spinout Anew
Chinese tech giant ByteDance, best known as the parent of TikTok, has completed a $290m financing for its AI drug discovery spinout Anew Labs.
News
AI spots drugs that may be repurposed for priority pathogen
Researchers have used AI algorithms to sift through thousands of drug molecules and identify some with activity against problem pathogen S pneumoniae.
News
FDA unveils framework for its expedited IND pilot
The FDA has published the design of its expedited Investigational New Drug pilot, part of a plan to restore US competitiveness in clinical research.
News
Electra sets terms for IPO, hoping to raise up to $347m
Electra Therapeutics has moved ahead with plans for an IPO, seeking to raise funds for its drug for the rare and life-threatening disease sHLH.
News
GSK wagers $750m on Chimagen multiple myeloma therapy
GSK has continued a drive to bulk up its pipeline, taking global rights to a T-cell engager for multiple myeloma, developed by China's Chimagen Bio.
Debates & Insights
News
Press Releases
Editor's Picks
Editor's Picks
